Pacific Northwest Prostate Cancer SPORE Gets $11.3M in NCI Renewal Funds | GenomeWeb

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center has won an $11.3 million competitive renewal grant from the National Cancer Institute to continue funding for a prostate cancer research consortium that pursues a range of projects focused on genetic and molecular medicine.

The grant renews support of the Pacific Northwest Prostate Cancer SPORE (Specialized Programs of Research Excellence) program, which launched in 2002, Fred Hutch said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.